Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations
Publication
, Journal Article
Baba, T; Mori, S; Matsumura, N; Bernardini, M; Fujii, S; Berchuck, A; Murphy, SK
Published in: GYNECOLOGIC ONCOLOGY
March 1, 2008
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2008
Volume
108
Issue
3
Start / End Page
S72 / S72
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Baba, T., Mori, S., Matsumura, N., Bernardini, M., Fujii, S., Berchuck, A., & Murphy, S. K. (2008). Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY, 108(3), S72–S72.
Baba, T., S. Mori, N. Matsumura, M. Bernardini, S. Fujii, A. Berchuck, and S. K. Murphy. “Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations.” GYNECOLOGIC ONCOLOGY 108, no. 3 (March 1, 2008): S72–S72.
Baba T, Mori S, Matsumura N, Bernardini M, Fujii S, Berchuck A, et al. Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY. 2008 Mar 1;108(3):S72–S72.
Baba, T., et al. “Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, ACADEMIC PRESS INC ELSEVIER SCIENCE, Mar. 2008, pp. S72–S72.
Baba T, Mori S, Matsumura N, Bernardini M, Fujii S, Berchuck A, Murphy SK. Microarray analysis identifies NSC668814 as a potentially active chemotherapeutic agent for platinum-resistant ovarian cancers with TP53 mutations. GYNECOLOGIC ONCOLOGY. ACADEMIC PRESS INC ELSEVIER SCIENCE; 2008 Mar 1;108(3):S72–S72.
Published In
GYNECOLOGIC ONCOLOGY
ISSN
0090-8258
Publication Date
March 1, 2008
Volume
108
Issue
3
Start / End Page
S72 / S72
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis